Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | The challenges associated with treating elderly patients with ALL

Marlise Luskin • 28 Sep 2022
SOHO 2022
Acute Lymphoblastic Leukemia Leukemia

Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute, Boston, MA, highlights the challenges of treating elderly patients with acute lymphoblastic leukemia (ALL) and the importance of discovering novel regimens that may be better tolerated by this patient population. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Marlise Luskin

1:28
Venetoclax & dose-reduced chemotherapy for the treatment of older adults with B-ALL and T-ALL
Marlise Luskin • 10 Dec 2023
2:08
Inotuzumab ozogamicin & venetoclax in the treatment of B-ALL: findings from a Phase I trial
Marlise Luskin • 10 Dec 2023
2:34
Asciminib plus dasatinib for the treatment of Ph+ B-ALL: insights from a Phase I trial
Marlise Luskin • 10 Dec 2023
0:56
Long-term overall survival of AYA patients with ALL who complete therapy on DFCI Consortium trials
Marlise Luskin • 11 Dec 2022

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals